Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jan;2(1):49-51.
doi: 10.4103/0976-500X.77118.

Fingolimod (FTY720): First approved oral therapy for multiple sclerosis

Sushil Sharma  1 , A G Mathur, Sapna Pradhan, D B Singh, Sparsh Gupta
Affiliations

Fingolimod (FTY720): First approved oral therapy for multiple sclerosis

Sushil Sharma et al. J Pharmacol Pharmacother. 2011 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared

References

    1. Noseworthy JH, Lucchinetti CF, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med. 2000;343:938–52. - PubMed
    1. Compston A, Coles A. Multiple sclerosis. Lancet. 2002;359:1221–31. - PubMed
    1. Rosati G. The prevalence of multiple sclerosis in the world: An update. Neurol Sci. 2001;22:117–39. - PubMed
    1. Vasiliou S. Oral fingolimod for the treatment of relapsing-remitting multiple sclerosis. Drugs Today. 2010;46:315–25. - PubMed
    1. FDA approves first oral drug to reduce MS relapses. Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm226755.htm [cited in 2010]

LinkOut - more resources